Biofrontera

-$0.89 (-13.82%) As of 4:46 PM UTC today

Why Robinhood?

You can buy or sell Biofrontera and other stocks, options, and ETFs commission-free!

About BFRA

Biofrontera AG engages in the development, sale and distribution of dermatological drugs and medical cosmetics for the care, protection and treatment of the skin. Its products include Ameluz, BF-RhodolesXepi and Belixos.

CEO
Hermann Lübbert
Employees
149
Headquarters
Leverkusen, Nordrhein-Westfalen
Founded
1997

BFRA Key Statistics

Market Cap
140.56M
Price-Earnings Ratio
Dividend Yield
Average Volume
205.76K
High Today
$6.01
Low Today
$5.51
Open Price
$5.93
Volume
102.69K
52 Week High
$55.00
52 Week Low
$4.67

BFRA Earnings

-$0.34
-$0.22
-$0.10
$0.02
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.25 per share
Actual
Available May 11

You May Also Like

TXN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure